| abstract |
1. The compound of formula I or any stereoisomeric forms thereof or a mixture of stereoisomeric forms in any ratio or a physiologically acceptable salt thereof: where ring A is a 3-membered-12-membered monocyclic, bicyclic or spirocyclic ring which contains 0, 1 or 2 identical or different heteroatoms selected from the series consisting of N, N (R), O, S, S (O) and S (O), and which is saturated or contains 1 double bond, provided that A is not a bicyclo [3.1 .0] hexane or bicyclo [3.2.0] heptane ring bearing the groups N (R) and C (O) -R in its position 3, and not an octahydro-pentalene, octahydroindene or decahydroazulene ring bearing the N (R) and C (O) -R groups in its position 2, where ring A is optionally substituted on the ring carbon atoms by one or more identical or different substituents selected from the series consisting of halogen, R, R, (CC) -alkenyl, HO-, RO-, phenyl- (CC) -alkyl-O-, RC (O) -O-, RS (O) -O-, RS ( O) -, HN-, R-NH-, RN (R) -, RC (O) -NH-, RC (O) -N (R) -, RS (O) -NH-, RS (O) - N (R) -, RC (O) -, HO-C (O) -, ROC (O) -, HN-C (O) -, R-NH-C (O) -, RN (R) -C (O) -, HN-S (O) -, R-NH-S (O) -, RN (R) -S (O) -, FS-, NC-, oxo and methylene; Y is selected from the series consisting of from N (R), S, O, C (R) = C (R), N = C (R) and C (R) = N; Z is selected and from a series consisting of N and C (R); R is selected from a series consisting of hydrogen and R; R is selected from a series consisting of (CC) -alkyl, (CC) -cycloalkyl and (CC) -cycloalkyl- (CC) - alkyl-; R are (CC) -alkyl, which is substituted with one or more identical or different substituents selected from the series consisting of HO- and (CC) -alkyl-O-; R is selected from the series consisting of hydrogen and R; R , R, R, R, R, R, R and R, regardless of each other group, R, R, R, R, R, R, R and R are selected from the group consisting of (CC) -alkyl, (CC) -alkenyl, (CC ) -alkynyl, (CC) -cycloalkyl and (CC) -cycloalkyl- (CC) -alkyl-, all of which are optional |